Adefovir Dipivoxil
Form: Oral tablets
Strength: 10 mg
Reference Brands: Hepsera® (EU & US)
Category: Hepatitis
Adefovir Dipivoxil is an oral antiviral nucleotide analog used to treat chronic Hepatitis B virus (HBV) infection. Available as 10 mg tablets, it inhibits viral DNA polymerase, preventing HBV replication and reducing viral load. Marketed primarily as Hepsera® by Gilead Sciences, Adefovir Dipivoxil is FDA and EMA approved and widely prescribed in both the US and EU. It is especially effective for patients with lamivudine-resistant HBV strains. Pharma B2B suppliers rely on Adefovir Dipivoxil as a key medication in managing chronic Hepatitis B infections and improving patient outcomes.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View More Get Enquiry
Glecaprevir/Pibrentasvir
Strength: Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®,
View More Get Enquiry
Ribavirin
Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View More Get Enquiry
Tenofovir Alafenamide (TAF)
Strength: 25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy® (EU & US)
View More Get Enquiry